| Literature DB >> 29979781 |
Caiyuan Zhao1, Hongtuo Fu1,2, Shengming Sun2, Hui Qiao2, Wenyi Zhang2, Shubo Jin2, Sufei Jiang2, Yiwei Xiong2, Yongsheng Gong2.
Abstract
White spot syndrome virus (WSSV) is one of the most devastating pathogens of cultured shrimp, responsible for massive loss of its commercial products worldwide. The oriental river prawn Macrobrachium nipponense is an economically important species that is widely farmed in China and adult prawns can be infected by WSSV. However, the molecular mechanisms of the host pathogen interaction remain unknown. There is an urgent need to learn the host pathogen interaction between M. nipponense and WSSV which will be able to offer a solution in controlling the spread of WSSV. Next Generation Sequencing (NGS) was used in this study to determin the transcriptome differences by the comparison of control and WSSV-challenged moribund samples, control and WSSV-challenged survived samples of hepatopancreas in M. nipponense. A total of 64,049 predicted unigenes were obtained and classified into 63 functional groups. Approximately, 4,311 differential expression genes were identified with 3,308 genes were up-regulated when comparing the survived samples with the control. In the comparison of moribund samples with control, 1,960 differential expression genes were identified with 764 genes were up-regulated. In the contrast of two comparison libraries, 300 mutual DEGs with 95 up-regulated genes and 205 down-regulated genes. All the DEGs were performed GO and KEGG analysis, overall a total of 85 immune-related genes were obtained and these gene were groups into 13 functions and 4 KEGG pathways, such as protease inhibitors, heat shock proteins, oxidative stress, pathogen recognition immune receptors, PI3K/AKT/mTOR pathway, MAPK signaling pathway and Ubiquitin Proteasome Pathway. Ten genes that valuable in immune responses against WSSV were selected from those DEGs to furture discuss the response of host to WSSV. Results from this study contribute to a better understanding of the immune response of M. nipponense to WSSV, provide information for identifying novel genes in the absence of genome of M. nipponense. Furthermore, large number of transcripts obtained from this study could provide a strong basis for future genomic research on M. nipponense.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29979781 PMCID: PMC6034857 DOI: 10.1371/journal.pone.0200222
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Primer sequences of genes used for quantitative real-time PCR.
| Name | Sequence |
|---|---|
| TSPAN8-F | |
| TSPAN8-R | |
| DPAGT1-F | |
| DPAGT1-R | |
| Gag-pol-F | |
| Gag-pol-R | |
| ARSB-F | |
| ARSB-R | |
| MKK2-F | |
| MKK2-R | |
| PDK-F | |
| PDK-R | |
| ILK-F | |
| ILK-R | |
| AP-F | |
| AP-R | |
| ERI3-F | |
| ERI3-R | |
| ZMYM1-F | |
| ZMYM1-R | |
| GST-F | |
| GST-R | |
| Cu/ZnSOD 4 -F | |
| Cu/ZnSOD 4 -R | |
| HSP21-F | |
| HSP21-R | |
| IRF-F | |
| IRF-R | |
| ERK-F | |
| ERK-R | |
| MKK4-F | |
| MKK4-R | |
| JNK-F | |
| JNK-R | |
| IAP-F | |
| IAP-R | |
| Ferritin-F | |
| Ferritin-R | |
| β-actin-F | |
| β-actin-R |
Quality of sequencing data.
| Sample | Raw reads | Clean reads | Clear base pairs (bp) | Q30 (%) | N(%) | GC(%) |
|---|---|---|---|---|---|---|
| control_sample1 | 52,584,444 | 51,011,136 | 7,645,216,841 | 93.49% | 0.00% | 44.00% |
| control_sample2 | 52,758,426 | 51,257,620 | 7,682,256,321 | 93.68% | 0.00% | 44.00% |
| control_sample3 | 52,472,172 | 50,576,016 | 7,579,712,371 | 92.82% | 0.00% | 45.00% |
| moribund_sample1 | 50,682,176 | 50,081,386 | 7,509,930,143 | 95.19% | 0.00% | 44.00% |
| moribund_sample2 | 52,553,448 | 51,084,812 | 7,656,384,701 | 93.72% | 0.00% | 44.00% |
| moribund_sample3 | 52,538,736 | 50,922,030 | 7,631,624,230 | 93.46% | 0.00% | 44.00% |
| survived_sample1 | 50,694,464 | 50,013,362 | 7,499,387,721 | 94.81% | 0.00% | 43.00% |
| survived_sample2 | 52,533,610 | 51,005,096 | 7,644,309,325 | 93.61% | 0.00% | 44.00% |
| survived_sample3 | 52,679,244 | 48,593,168 | 7,283,243,709 | 90.95% | 0.00% | 45.00% |
Fig 1Length distribution of assembled transcripts and unigenes.
Summary of annotations of all assembled unigenes.
| Number of unigenes | Percentage (%) | |
|---|---|---|
| Total length of unigenes | 84,694,421 | |
| Mean length of unigenes | 1,322.34 | |
| N50 of unigenes | 2,205 | |
| Total number of unigenes | 64,049 | 100% |
| Total annotated | 21,063 | 32.89% |
| NCBI Nr annotated | 20,187 | 31.52% |
| Swiss-Prot annotated | 17,578 | 27.44% |
| KOG annotated | 15,211 | 23.75% |
| KEGG annotated | 7,759 | 12.11% |
| GO annotated | 16,573 | 25.88% |
Fig 2Gene ontology (GO) classification of 16,573 protein annotated unigenes from the three hepatopancreas samples (control, moribund and survived groups).
The three main GO categories include biological process (red), cellular component (green), and molecular function (blue). Each bar represents the relative abundance of unigenes classified under each category at level 2.
The top 50 statistically signifcant KEGG classifcations.
The rank of a pathway is based on the number of all unigenes that classified into this pathway.
| No. | Pathway ID | Pathway definition | Number of unigenes |
|---|---|---|---|
| 1 | ko05200 | Pathways in cancer | 381(2.90%) |
| 2 | ko04144 | Endocytosis | 347(2.65%) |
| 3 | ko04142 | Lysosome | 337(2.58%) |
| 4 | ko05165 | Human papillomavirus infection | 326(2.50%) |
| 5 | ko04141 | Protein processing in endoplasmic reticulum | 324(2.49%) |
| 6 | ko05016 | Huntington's disease | 324(2.50%) |
| 7 | ko05010 | Alzheimer's disease | 312(2.42%) |
| 8 | ko04151 | PI3K-Akt signaling pathway | 310(2.41%) |
| 9 | ko05205 | Proteoglycans in cancer | 308(2.40%) |
| 10 | ko05169 | Epstein-Barr virus infection | 284(2.23%) |
| 11 | ko05166 | HTLV-I infection | 279(2.20%) |
| 12 | ko03040 | Spliceosome | 278(2.20%) |
| 13 | ko04145 | Phagosome | 277(2.20%) |
| 14 | ko03010 | Ribosome | 275(2.19%) |
| 15 | ko03013 | RNA transport | 272(2.18%) |
| 16 | ko04510 | Focal adhesion | 269(2.16%) |
| 17 | ko05203 | Viral carcinogenesis | 267(2.15%) |
| 18 | ko04810 | Regulation of actin cytoskeleton | 257(2.09%) |
| 19 | ko04932 | Non-alcoholic fatty liver disease (NAFLD) | 252(2.06%) |
| 20 | ko04210 | Apoptosis | 248(2.03%) |
| 21 | ko04015 | Rap1 signaling pathway | 244(2.01%) |
| 22 | ko05012 | Parkinson's disease | 242(2.00%) |
| 23 | ko04530 | Tight junction | 241(2.00%) |
| 24 | ko00190 | Oxidative phosphorylation | 238(1.99%) |
| 25 | ko04014 | Ras signaling pathway | 234(1.96%) |
| 26 | ko04010 | MAPK signaling pathway | 225(1.90%) |
| 27 | ko00230 | Purine metabolism | 222(1.89%) |
| 28 | ko05164 | Influenza A | 219(1.87%) |
| 29 | ko04140 | Autophagy—animal | 216(1.86%) |
| 30 | ko05167 | Kaposi's sarcoma-associated herpesvirus infection | 209(1.81%) |
| 31 | ko01200 | Carbon metabolism | 208(1.81%) |
| 32 | ko05418 | Fluid shear stress and atherosclerosis | 204(1.79%) |
| 33 | ko04013 | MAPK signaling pathway—fly | 204(1.80%) |
| 34 | ko04024 | cAMP signaling pathway | 203(1.80%) |
| 35 | ko05168 | Herpes simplex infection | 201(1.79%) |
| 36 | ko04218 | Cellular senescence | 198(1.77%) |
| 37 | ko04120 | Ubiquitin mediated proteolysis | 195(1.76%) |
| 38 | ko04921 | Oxytocin signaling pathway | 191(1.74%) |
| 39 | ko05206 | MicroRNAs in cancer | 184(1.69%) |
| 40 | ko04910 | Insulin signaling pathway | 183(1.69%) |
| 41 | ko05152 | Tuberculosis | 181(1.68%) |
| 42 | ko04062 | Chemokine signaling pathway | 180(1.68%) |
| 43 | ko04621 | NOD-like receptor signaling pathway | 177(1.67%) |
| 44 | ko04360 | Axon guidance | 176(1.67%) |
| 45 | ko04022 | cGMP—PKG signaling pathway | 176(1.68%) |
| 46 | ko04150 | mTOR signaling pathway | 174(1.67%) |
| 47 | ko04217 | Necroptosis | 174(1.68%) |
| 48 | ko04919 | Thyroid hormone signaling pathway | 164(1.61%) |
| 49 | ko05161 | Hepatitis B | 162(1.60%) |
| 50 | ko04020 | Calcium signaling pathway | 160(1.59%) |
Fig 3Digital gene expression between moribund samples and control (A), digital gene expression between survived samples and control (B). Each unigene was presented as a point. The x- and y-axis are the log2-fold change and the log10 P-value of the normalized expression level (FPKM) of gene between the two compared groups. Red and green points indicate aberrantly change at the absolute value of log2 (FPKM ratio in two compared groups) ≥ 1 and FDR ≤ 0.001. Red points represent up-regulated genes. Green points represent down-regulated genes. Blue points represent insignificant differentially expressed genes.
Fig 4The top 10 GO enrichment terms of DEGs in each category at level 2.
The three GO categories include biological process (red), cellular component (green), and molecular function (blue). A means the enrichment GO terms of DEGs from the comparison between moribund samples and control. B means the enrichment GO terms of DEGs from the comparison between survived samples and control. The x- and y-axis are the GO terms and the log10 P-value of corresponding GO terms.
Top 20 differentially expressed pathways of two comparison libraries.
| 1 | ko00980 | Metabolism of xenobiotics by cytochrome P450 | 29(1.48%) | 2.04E-25 |
| 2 | ko05204 | Chemical carcinogenesis | 29(1.48%) | 3.90E-24 |
| 3 | ko00982 | Drug metabolism—cytochrome P450 | 25(1.28%) | 4.87E-22 |
| 4 | ko00981 | Insect hormone biosynthesis | 16(0.82%) | 4.55E-16 |
| 5 | ko00040 | Pentose and glucuronate interconversions | 19(0.97%) | 3.00E-14 |
| 6 | ko00830 | Retinol metabolism | 18(0.92%) | 8.91E-14 |
| 7 | ko00983 | Drug metabolism—other enzymes | 18(0.92%) | 8.45E-13 |
| 8 | ko00140 | Steroid hormone biosynthesis | 14(0.71%) | 8.22E-12 |
| 9 | ko00053 | Ascorbate and aldarate metabolism | 12(0.61%) | 6.38E-10 |
| 10 | ko00480 | Glutathione metabolism | 16(0.82%) | 2.38E-09 |
| 11 | ko00860 | Porphyrin and chlorophyll metabolism | 14(0.71%) | 2.92E-09 |
| 12 | ko00590 | Arachidonic acid metabolism | 9(0.46%) | 4.67E-06 |
| 13 | ko01524 | Platinum drug resistance | 11(0.56%) | 6.45E-06 |
| 14 | ko04977 | Vitamin digestion and absorption | 7(0.36%) | 7.62E-06 |
| 15 | ko00780 | Biotin metabolism | 3(0.15%) | 3.10E-05 |
| 16 | ko00100 | Steroid biosynthesis | 4(0.20%) | 0.000181 |
| 17 | ko01220 | Degradation of aromatic compounds | 3(0.15%) | 0.000991 |
| 18 | ko05033 | Nicotine addiction | 2(0.10%) | 0.00153 |
| 19 | ko00604 | Glycosphingolipid biosynthesis—ganglio series | 3(0.15%) | 0.003107 |
| 20 | ko04146 | Peroxisome | 9(0.16%) | 0.004405 |
| 1 | ko03010 | Ribosome | 104(2.41%) | 5.91E-18 |
| 2 | ko05130 | Pathogenic Escherichia coli infection | 43(1.00%) | 3.60E-07 |
| 3 | ko04145 | Phagosome | 78(1.80%) | 5.92E-07 |
| 4 | ko00710 | Carbon fixation in photosynthetic organisms | 19(0.44%) | 6.01E-05 |
| 5 | ko04022 | cGMP—PKG signaling pathway | 49(1.14%) | 7.78E-05 |
| 6 | ko04921 | Oxytocin signaling pathway | 52(1.21%) | 9.50E-05 |
| 7 | ko04011 | MAPK signaling pathway—yeast | 18(0.42%) | 0.000107 |
| 8 | ko00190 | Oxidative phosphorylation | 61(1.42%) | 0.000184 |
| 9 | ko04020 | Calcium signaling pathway | 44(1.02%) | 0.000225 |
| 10 | ko03015 | mRNA surveillance pathway | 40(0.93%) | 0.000229 |
| 11 | ko04964 | Proximal tubule bicarbonate reclamation | 14(0.32%) | 0.000263 |
| 12 | ko00010 | Glycolysis / Gluconeogenesis | 33(0.77%) | 0.000275 |
| 13 | ko04721 | Synaptic vesicle cycle | 28(0.65%) | 0.000563 |
| 14 | ko04540 | Gap junction | 36(0.84%) | 0.000615 |
| 15 | ko04910 | Insulin signaling pathway | 47(1.10%) | 0.000808 |
| 16 | ko05031 | Amphetamine addiction | 25(0.58%) | 0.000827 |
| 17 | ko04152 | AMPK signaling pathway | 36(0.84%) | 0.000843 |
| 18 | ko01200 | Carbon metabolism | 52(1.21%) | 0.000925 |
| 19 | ko05152 | Tuberculosis | 46(1.07%) | 0.001149 |
| 20 | ko04151 | PI3K-Akt signaling pathway | 72(1.67%) | 0.001306 |
Fig 5Significantly differentiated expressed genes that were identified by KEGG as involved in the PI3K/AKT signaling pathway.
Red boxes indicate significantly increased expression. Green boxes indicate significantly decreased expression. Yellow boxes indicate both significantly increased and decreased expression. Blue boxes indicate unchanged expression.
Fig 6Statistic of differently expressed genes in the WSSV-infected samples with control.
The first column in the chart means differently expressed gene numbers in the comparison of moribund samples and control. The second column in the chart means differently expressed gene numbers in the comparison of survived samples and control. Red parts indicate up-regulated genes and green parts indicate down-regulated genes.
Fig 7Differently expressed genes in the WSSV-infected samples with control.
The left big circle represented DEGs in the comparison of survived samples and control. The right small circle represented DEGs in the comparison of moribund samples and control. Gene number was shown with up arrow and down arrow representing up-regulation and down-regulation of these DEGs, respectively. Mutual genes in the two comparison libraries were closed in the area cross two circles.
Fig 8Comparison of the expression profiles of selected genes as determined by RNA-Seq (Illumina Hiseq2500TM sequencing) and qRT-PCR.
The letter “A” and “B” in the RNA-Seq and qRT-PCR mean the comparison of expression profiles of selected genes between control and moribund samples (the correlation coefficient was 0.92), the comparison of expression profiles of selected genes between control and survived samples (the correlation coefficient was 0.95), respectively. Target gene abbreviations are as follows: TSPAN8 –TSPAN8, DPAGT1 –UDP-N-acetylglucosamine—dolichyl-phosphate N-acetylglucosaminephosphotransferase, Gag-pol –Gag-Pol polyprotein, ARSB–arylsulfatase B, MKK2 –MAP kinase-activated protein kinase 2, PDK–pyruvate dehydrogenase (acetyl-transferring) kinase, ILK–integrin-linked protein kinase, AP–acid phosphatase, ERI3 –ERI1 exoribonuclease 3, ZMYM1 –zinc finger MYM-type protein 1. Error bars indicated standard deviations of averages from three replicates.
Candidate genes involved in M. nipponensis immune response.
| Candidate genes involved in the comparison of survived samples with control | |||
|---|---|---|---|
| Category or gene ID | Homologous function | Species | FC |
| CL11768Contig1 | cathepsin S | -3.17 | |
| CL7706Contig1 | cathepsin B1 | Clonorchis sinensis | 8.68 |
| comp79933_c0_seq1_2 | cathepsin B | 7.91 | |
| CL1Contig9793 | Cathepsin C | 8.15 | |
| CL18412Contig1 | Cathepsin L precursor | 7.34 | |
| comp35611_c0_seq3_2 | 26S protease regulatory subunit, putative | 7.41 | |
| CL6002Contig1 | serine protease inhibitor A3G | -5.97 | |
| comp75245_c0_seq2_2 | serine protease inhibitor | Inf | |
| Signal transduction | |||
| comp32201_c0_seq1_2 | ring box protein | 6.98 | |
| comp86621_c0_seq3_2 | casein kinase 1 epsilon | 2.54 | |
| CL16567Contig1 | casein kinase I isoform delta | 9.01 | |
| CL13787Contig1 | Casein kinase II subunit beta | 6.05 | |
| comp77179_c0_seq6_2 | casein kinase I isoform gamma-3 | 7.37 | |
| comp16015_c0_seq1_2 | regulatory associated protein of mTOR | Inf | |
| comp36351_c0_seq1_2 | FKBP12-rapamycin complex-associated protein | Inf | |
| comp36351_c1_seq1_2 | ataxia telangiectasia mutated (atm)-related | Inf | |
| CL10155Contig1 | Activating transcription factor 4 | -3.16 | |
| comp87614_c0_seq6_2 | serine/threonine-protein kinase PLK4-like | Hyalella azteca | 2.37 |
| CL4900Contig1 | serine/threonine-protein kinase Sgk1 isoform c | Mus musculus | -3.67 |
| comp49509_c0_seq1_2 | Serine/threonine-protein kinase mig-15 | Inf | |
| comp78464_c0_seq1_2 | serine/threonine-protein kinase Nek4 isoform X1 | Inf | |
| comp79342_c0_seq3_2 | serine/threonine-protein kinase PRP4 | 9.14 | |
| comp71890_c0_seq3_2 | serine/threonine-protein kinase 25 | 8.91 | |
| CL17850Contig1 | serine/threonine-protein kinase par-1 | 8.09 | |
| comp78560_c0_seq3_2 | serine/threonine-protein kinase NIM1 | 7.48 | |
| comp65802_c0_seq1_2 | serine/threonine-protein kinase TTK/MPS1 | 7.36 | |
| CL2265Contig2 | c-Jun N-terminal kinase | 7.10 | |
| comp72868_c0_seq2_2 | MAP kinase phosphatase | 7.00 | |
| CL1Contig13196 | MAP kinase-activated protein kinase 2 | 3.46 | |
| comp77070_c0_seq6_2 | extracellular signal-regulated kinase 1/2 | 9.04 | |
| CL14855Contig1 | Mitogen-activated protein kinase (MAPK) kinase MKK4 | 7.69 | |
| comp81318_c0_seq5_2 | Max protein | 6.58 | |
| comp76201_c0_seq1_2 | growth factor receptor-binding protein 2 | 7.25 | |
| CL1Contig6129 | CASP8 and FADD-like apoptosis regulator | -3.79 | |
| comp78381_c0_seq11_2 | run domain Beclin-1 interacting and cystein-rich containing protein | 7.07 | |
| CL20513Contig1 | programmed cell death | 8.31 | |
| comp88816_c0_seq1_2 | prohibitin | 9.96 | |
| comp34968_c0_seq1_2 | ADP-ribosylation factor-like 6 | 8.94 | |
| comp83430_c3_seq9_2 | ADP-ribosylation factor-binding protein GGA1 | 9.32 | |
| CL7706Contig1 | ADP-ribosylation factor | 8.68 | |
| comp34891_c0_seq2_2 | ADP-ribosylation factor-like 3 | 7.86 | |
| CL18876Contig1 | adp-ribosylation factor 2 | 7.60 | |
| comp35052_c0_seq1_2 | ADP-ribosylation factor-like protein 2-binding protein | 7.55 | |
| comp79928_c0_seq3_2 | integrin | 9.57 | |
| comp87970_c0_seq2_2 | heat shock protein 21 | 3.50 | |
| CL11343Contig1 | heat shock protein 70 | -3.15 | |
| CL12763Contig1 | thioredoxin | -2.96 | |
| comp32414_c0_seq1_2 | peroxiredoxin 3 | 9.88 | |
| CL10956Contig1 | peroxiredoxin-1 | -3.23 | |
| CL18982Contig1 | microsomal glutathione S-transferase 1 isoform 2 | -3.09 | |
| comp60048_c0_seq1_2 | Mn-SOD | 8.75 | |
| comp32905_c0_seq1_2 | cytosolic Cu/Zn superoxide dismutase | 7.24 | |
| CL10185Contig1 | C-type lectin domain family 4, member e | 3.63 | |
| CL10259Contig1 | C-type lectin domain family 4, member d | 3.62 | |
| CL20347Contig1 | metallothionein 2 | -4.32 | |
| CL10847Contig1 | profilin 1, isoform CRA_c | -4.31 | |
| CL17138Contig1 | Selenoprotein W | 7.62 | |
| CL681Contig3 | selenoprotein-like | -3.74 | |
| CL10615Contig1 | Selenoprotein X1 | -3.97 | |
| comp88625_c0_seq1_2 | soma ferritin-like | 10.02 | |
| comp66351_c0_seq1 | chitinase 4 | -2.90 | |
| CL1Contig9190 | chitinase 3C | -3.60 | |
| comp74350_c0_seq6_2 | Actin-related protein 6 | 8.73 | |
| CL21493Contig1 | actin | 7.55 | |
| CL10277Contig1 | calponin-3 | 7.67 | |
| comp69528_c0_seq3_2 | Calmodulin, partial | 7.54 | |
| comp61515_c0_seq1 | interferon regulatory factor | Inf | |
| CL10224Contig1 | complement factor B | -3.19 | |
| CL1201Contig1 | complement C3 isoform X1 | -3.21 | |
| CL12167Contig1 | tumor necrosis factor ligand 1 | -3.22 | |
| CL1794Contig1 | crustin | -3.80 | |
| CL1Contig6818 | cathepsin C | -2.76 | |
| CL3395Contig1 | cathepsin D | -2.32 | |
| CL10339Contig1 | cathepsin L | -2.15 | |
| CL11978Contig1 | cathepsin A | 5.92 | |
| CL1Contig13196 | MAP kinase-activated protein kinase 2 | 4.01 | |
| CL440Contig1 | inhibitor of apoptosis protein | 1.73 | |
| comp64523_c0_seq2 | ADP-ribosylation factor-like protein 6 | 9.47 | |
| CL1514Contig2 | integrin alpha 4 | -4.09 | |
| comp85041_c1_seq7_2 | thioredoxin-like protein 4A isoform X2 | 3.03 | |
| CL22077Contig1 | glutathione S-transferases | -1.66 | |
| CL13799Contig1 | glutathione peroxidase-like | -1.46 | |
| CL153Contig3 | copper/zinc superoxide dismutase isoform 4 | 4.12 | |
| comp64778_c0_seq3 | heat shock protein 21 | 3.46 | |
| CL3679Contig1 | heat shock protein 70 | -4.40 | |
| comp67093_c1_seq1_3 | C-type lectin 2 | -2.46 | |
| CL14655Contig1 | lipopolysaccharide and beta-1,3-glucan binding protein | 19.33 | |
| CL1Contig9190 | chitinase 3C | -3.52 | |
| comp40522_c0_seq1_3 | chitinase 1 | -2.61 | |
| comp64036_c1_seq4_3 | chitinase 3B | -2.31 | |
| CL1Contig3188 | adenosine deaminase CECR1-like | -1.89 | |
Inf means the gene only expressed in the survived samples.
a Fold changes (log2 ratio) in gene expression.
PRPs-pattern recognition proteins, ProPO-prophenoloxidase.
Fig 9Expression profiles of genes in hepatopancreas from WSSV challenged M. nipponensis.
Expression profiles of GST (A), Cu/ZnSOD 4 (B), HSP21 (C), IRF (D), ERK (E), MKK2 (F), MKK4 (G), JNK (H), IAP (I) and Ferritin (J) in hepatopancreas from WSSV challenged M. nipponensis. Real-time RT-PCR was performed in triplicate for each sample. Expression values were normalized to those of β-actin using the Livak (2-ΔΔCT) method and the data were provided as the means ± SD of triplicate assays. Expression level detected at 0 h was set as 1.0. Statistical significance was determined by Student's t-test (* indicates P < 0.05, ** indicates P < 0.01).
Fig 10Significantly differentiated expressed genes that were identified by KEGG as involved in the PI3K/AKT signaling pathway.
Red boxes indicate significantly increased expression. Green boxes indicate significantly decreased expression. Yellow boxes indicate both significantly increased and decreased expression. Blue boxes indicate unchanged expression.
Fig 11Significantly differentiated expressed genes that were identified by KEGG as involved in the MAPK signaling pathway.
Red boxes indicate significantly increased expression. Green boxes indicate significantly decreased expression. Yellow boxes indicate both significantly increased and decreased expression. Blue boxes indicate unchanged expression.